If the virus is contained within the digestive tract individuals may only have flu like symptoms, but if the virus spreads to the bloodstream due to a "leaky gut" individuals might present with non-paralytic and paralytic poliomyelitis, which are forms that affect the brain and spinal cord. Some symptoms might include back stiffness, muscle weakness, lack of muscular control, and abnormal reflexes. The treatment for poliomyelitis focuses on palliative care, physical therapy, and sometimes antibiotics are necessary. Polio’s impact on the central nervous system typically has the greatest influence on the respiratory system, which is due to the weakened diaphragm. The disease has the potential to cripple the individual and in rare cases the infection can be fatal.
Individuals who were previously infected might be diagnosed with post-polio syndrome, which can present 30+ years after the initial infection. Post-polio syndrome will include symptoms like muscle weakness in the affected areas, but may also include new areas.
How is the vaccine made?
The IPV contains three types of poliovirus; Mahoney, MEF-1, and Saukett. All three of the viral strains are cultivated from the kidneys of African green monkeys. Other ingredients include; Eagle MEM modified medium, newborn calf serum protein, M-199, phenoxyethanol, formaldehyde, neomycin, streptomycin, and polymyxin B.
The VACCIN OPV contains two types of poliovirus; LS c2ab, and Leon 12alb strain. These polio strains are also cultivated from the kidneys of African green monkeys. Other ingredients include; Human albumin, HEPES buffer solution, and magnesium chloride solution (containing polysorbate 80 and phenol red).
The OPVERO OPV contains two types of poliovirus; P 712, Ch, 2ab strain and Leon 12alb strain. These polio strains are also cultivated from the kidneys of African green monkeys. Other ingredients include; Human albumin, HEPES buffer solution, magnesium chloride solution (containing polysorbate 80 and phenol red), and hydrochloric acid or sodium hydroxide for pH adjustment
According to the U.S. Department of Health and Human services (HRSA), the polio vaccine(s) can cause, “Paralytic Polio, acute complication or sequela, anaphylaxis or anaphylactic shock, death, disability, and injury” (HRSA, n.d.).
If you read the product inserts by Sanofi Pasteur and GlaxoSmithKline they state their product could produce; fever, seizures, inconsolable crying, Guillain-Barre Syndrome, anaphylactic reaction, brachial neuritis, demyelinating diseases of the CNS, peripheral mononeuropathy, cranial mononeuropathy, idiopathic thrombocytopenic purpura, thrombocytopenia, angioedema, encephalopathy, hypotonic-hypoesponsive episode, asthenia, lethargy, malaise, Sudden Infant Death Syndrome, edema, lymphadenopathy, thrombocytopenia, jaundice, liver function tests abnormal, arthralgia, convulsions, somnolence, parasthesia, paresis, neuritis, myelitis, post vaccination paralysis and rash.
Research On Polio Adverse Events
Non-polio acute flaccid paralysis (NPAFP); “In 2011, there were an extra 47,500 new cases of NPAFP. Clinically indistinguishable from polio paralysis but twice as deadly, the incidence of NPAFP was directly proportional to doses of oral polio received” (Vashisht, N., Puliyel, J., 2012).
Researchers have known that the injections of other vaccines contribute to paralysis stating;
A relationship was shown to exist between site of injection and site of paralysis in children injected no more than a month before onset of poliomyelitis with diphtheria toxoid, pertussis vaccine, or tetanus toxoid, or any combination of the three (Greenberg et al, 1952).
Vaccine Ingredient: Formaldehyde
Formaldehyde has been classified as a known human carcinogen (cancer causing substance) by the International Agency for Research on Cancer and as a probable human carcinogen by the U.S. Environmental Protection Agency. Research studies of workers exposed to formaldehyde have suggested an association between formaldehyde exposure and several cancers, including nasopharyngeal cancer and leukemia (National Cancer Institute, 2011).
Vaccine Ingredient: Polysorbate 80 or Tween 80
Typically, the vaccine is prepared using an adjuvant concentrate which contains lecithin (about 5% to about 15 % wt/vol, preferably about 12% wt /vol) and STDCM (preferably about 25 mg/mL to about 50 mg mL) in squalene oil. The term % wt/vol means grams per 100 mL of liquid. The aqueous solution containing the isolated pZP glycoprotein is typically a phosphate-buffered saline (PBS) solution, and additionally preferably contains Tween 80 (about 0.2% vol/vol to about 0.8% vol/vol, preferably about 0.4% vol/vol) (PCT/US1998/027658, 1999).
Salk Commentary On The Polio Vaccine
Live virus vaccines against influenza and paralytic polio, for example, may in each instance cause the disease it is intended to prevent... Dr Jonas Salk, developer of first polio vaccine (Salk, J., Salk, D., 1977)
Vaccine Affects In Other Countries
Islamabad: A government inquiry has found that polio vaccines for infants funded by the Global Alliance for Vaccination and Immunisation (Gates Foundation) are causing deaths and disabilities in regional countries including Pakistan (Rana, S., 2011).
Dr. Neetu Vashisht and Dr. Jacob Puliyel of St. Stephens Hospital crated the report analyzing data from India's 10-year-old National Polio Surveillance Project, which is available online. Their findings, which were published in the Indian Journal of medical Ethics, revealed that rates of non-polio acute flaccid paralysis (NPAFP) have increase 1200% since the oral polio vaccine was introduced to India a decade ago (Freeman, E., 2012).
At the main hospital in Mbarara during the month of 1977 more than 600 children had died following polio vaccination. 600 children! So even some of the timid medical practitioners who were initially afraid to come out, started coming out giving information and saying 'Oh, we knew this oral polio vaccine was trouble because as soon as the child receives it, they get a temperature and their health goes downhill and there is nothing that you could do.' The oral polio vaccine in Uganda, Northern Tanzania, Rwands, Burundi, Congo and part of Kenya has become a hotly contested debate. Thousands of people, during the National Immunization Days in the months of July and September, go into the bush ans stay there for weeks. The army and police move house to house looking for children to vaccinate. At the same time, things that kill children like malaria, cholera, issues of stunted growth, sanitation, are completely untackled. (Kihura Nkuba, 2002).
BARELY one week after Niger State Government threatened to jail anybody who refused to allow polio vaccine to be administered on his or her child, 120 persons have been arrested for contravening the directive.
The Director of the State Primary Health Care Development Agency, Dr. Shehu Yabagi, who disclosed this to newsmen in Minna on Tuesday, said among the arrested persons were those who had consistently opposed the polio vaccine immunisation exercise in the state.
He pointed out that the persons were arrested at various locations in the state by the police as the agency sought to enforce the law that forbids rejection of the polio vaccine. (Opara, E., 2013).
Reports To The Vaccine Adverse Event Reporting System (VAERS)
61,444 events reported from the vaccine (IPV, and OPV) from 1989 to 2013. 90.58% were children under the age of 6 (MedAlerts, 2013).
1,269 Life Threatening 90.94% under the age of 6
23,446 ER Visit 92.61% under the age of 6
4,639 Hospitalized 87.75% under the age of 6
53 Extended Hospital Stay 81.13% under the age of 6
330 Disabled 80.61% under the age of 6
1348 Died 95.1% under the age of 3
Challenge A Microbe Change The Disease
Changing The Diagnostic Criteria
In the same Congressional Hearing the Representatives discussed that in 1959 77.5% of paralytic polio victims had received 3 doses of oral polio vaccine (OPV) in Massachusetts (Greenberg, B., 1962 pg. 94). The U.S. discontinued use of OPV due to its known contribution to causing paralytic polio in 2000 (de Oliveira, L., Struchiner, C., 2000).
MV Polio Strain Escape From Rockefeller Labs, New York
However it is a remarkable coincidence that a unique neurotropic strain of poliovirus was developed a few miles from an epidemic caused by a uniquely pathogenic strain of the virus. My theory would not be proved even if it could be shown that a Rockefeller worker had lived in Brooklyn. Nevertheless such an extraordinary epidemic requires an extraordinary explanation: it is the only suggestion to be offered so far. Correct or not, it provides a powerful message for everyone who works with pathogens (Wyatt, H., 2011).
Today's Monsanto... Yesterday's DDT ~ Poliomyelitis
Acute gastroenteritis occurs, with nausea, vomiting, abdominal pain, and diarrhea usually associated with extreme tenesmus. Coryza, cough and persistent sore throat are common, often followed by a persistent or recurrent feeling of constriction or a "lump" in the throat; occasionally the sensation of constriction extends substernally and to the back and may be associated with severe pain in either arm. Pain in the joints, generalized muscle weakness, apprehension and exhausting fatigue are usual; the latter are often so severe in the acute stage as to be described by some patients as "paralysis" (Biskind, M., 1949).
Simian Virus 40 (SV40)
IPV administered between 1955 and 1963 to about 98 million children and adults is assumed to be the primary source of human exposure to SV40 in the United States. In addition, experimental lots of OPV contaminated with SV40 are known to have been administered to about 10,000 people participating in clinical trials between 1959 and 1961 (IOM, 2002, pg. 22).
SV40 Presenting In Human Cancer Patients
The current understanding from pathologists and scientists who are discovering SV40 in the tumors of cancer patients determine that this "virus plays a role in tumor pathogenesis" (Shivapurkar et al., 2004). This virus has been found in brain tumors, bone cancers, mesotheliomas, lung cancer and most notably Non-Hodgkin's Lymphoma. As time goes on the implication of this exposure continues to be disconcerting regarding public health. One study found that children born after the exposure was eliminated have evidence of SV40 in their "tumors and normal tissues" (Butel et al., 1999). This could indicate the virus can be spread through person to person contact or by heritable DNA. Another disturbing finding documents that the cancerous tissues that contain SV40 do not respond to chemotherapy or radiation, which increases the mortality rate of the affected individuals. The U.S. health authority's reply to these findings remains stagnant, they continue to say they are monitoring the situation.
Here is a video of vaccine developer and SV40 researcher Dr. Maurice Hilleman discussing his experience with vaccine production, monkeys, SV40, and HIV.
Due to the controversy and external pressure Rolling Stone pulled the article, but that did not kill the story. A journalist Edward Hooper from the U.K. picked up where Curtis left off and traveled to the Congo to gain further insight regarding the CHAT oral polio vaccine and HIV. He published is research linking the CHAT OPV to HIV in a book titled "The River A Journey Back To The Source Of HIV And AIDS". Koprowski denies using chimpanzees in his manufacturing process but footage from his lab clearly shows chimpanzees. Edward Hooper's claims were discredited when one vile from one lot of CHAT oral polio vaccine was tested and found to be HIV negative.
CBS News then picked up the story and traveled to the Belgian Congo where they interviewed the local workers operating the Koprowski laboratory. The lead scientist at that location was Paul Osterrieth and all of the local workers validated that only chimpanzees were used in the production of the CHAT oral polio vaccine. They also supplied photographs and videos that corroborated their testimony. Osterrieth published a reply to these accusations in the journal Vaccine denying those claims. CBS uncovered documents that list chimpanzee use in the development of the OPV, and Pierre Doupagne who was the chief technician that cultured tissue for Paul Osterrieth validated that those samples were from chimpanzees.
Here again we find contradictory reports, and the appearance that reputations are more important to maintain rather than transparent accounts of the production of the CHAD OPV.
Dr. Maurice Hilleman a Merck vaccine developer admitted that the African Green monkeys, which were used to cultivate the polio vaccine were also infected with AIDS;
So I went down to see Bill Mann at the zoo in Washington DC and I told Bill Mann, I said "look, I got a problem and I don't know what the hell to do." Bill Mann is a real bright guy. I said that these lousy monkeys are picking it up while being stored in the airports in transit, loading, off loading. He said, very simply, you go ahead and get your monkeys out of West Africa and get the African Green, bring them into Madrid unload them there, there is no other traffic there for animals, fly them into Philadelphia and pick them up. Or fly them into New York and pick them up, right off the airplane. So we brought African Greens in and I didn't know we were importing the AIDS virus at the time.
Bill & Melinda Gates Foundation. (2012). Family planning. Global Health Program. Retrieved from http://www.gatesfoundation.org/global-health/Documents/family-planning-strategy.pdf
Biskind M. (1949). DDT poisoning and the elusive "Virus X:" A new cause for gastroenteritis. Am J Dig Dis. Vol 16 Num 3. pg. 79-84. PMID: 18113629
Butel et al. (1999). Molecular evidence of simian virus 40 infections in children. J Infect Dis. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10438386
CDC. (2011). Polio disease in-short. Department of Health and Human Services. Retrieved from http://www.cdc.gov/vaccines/vpd-vac/polio/in-short-both.htm
CDC. (2012). Poliomyelitis. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/vaccines/pubs/pinkbook/polio.html
Chen et al. (1994). The vaccine adverse event reporting system (VAERS). Vaccine. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8036829
Cooper, J. (1917). Agricultural Experiment Station. Research Bulletin No. 10. Retrieved from http://books.google.com/books?id=D3dCAAAAYAAJ&pg=RA2-PA34&lpg=RA2-PA34&dq=economic+entomology+So+far+as+our+experiments+with+guinea+pigs+1917&source=bl&ots=IFfkgz_3sw&sig=jW2Hj3uu_Np6e29vLGQCbmYcC6I&hl=en&ei=lLFvTpqkB6PnsQK4rfDRCQ&sa=X&oi=book_result&ct=result&resnum=1&sqi=2&ved=0CBsQ6AEwAA#v=onepage&q&f=false
de Oliveira, L., Struchiner, C. (2000). Vaccine-associated paralytic poliomyelitis: a retrospective cohort study of acute flaccid paralyses in Brazil. Int J Epidemiol. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10922356
Eddy et al. (1962). Identification of the oncogenic substance in rhesus monkey kidney cell culture as simian virus 40. Virology. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/13889129
Foster, M. (2011). Running behind the DDT truck. Mimi Foster. Retrieved from http://www.cospringsrealestatenews.com/running-behind-the-ddt-truck/
Freeman, E. (2012). India: Paralysis cases soar after oral polio vaccine introduced. Digital Journal. Retrieved from http://www.digitaljournal.com/article/323371
Furione et al. (1993). Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8102826
Gajdova et al. (1993). Delayed effects of neonatal exposure to Tween 80 on female reproductive organs in rats. Food Chem Toxicol. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8473002?dopt=Abstract
Goldman et al. (2003). What was the cause of Franklin Delano Roosevelt’s paralytic illness? J Med Biogr. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/14562158
Greenberg, B. (1962). Hearings before the committee on interstate and foreign commerce. House of Representatives 87th Congress, 2 Session on HR 10541: 94-112
Greenberg et al. (1952). The relation between recent injections and paralytic poliomyelitis in children. Am J. Public Health Nations Health. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1525737/?page=11
HRSA. (n.d.). Vaccine injury table. Health Resources and Services Administration. Retrieved from http://www.hrsa.gov/vaccinecompensation/vaccinetable.html
Haber et al. (2013). Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012. Pediatrics. Retrieved from http://pediatrics.aappublications.org/content/early/2013/05/08/peds.2012-2554.abstract
Hilleman, M. (1998). Discovery of simian virus 40 (SV40) and its relationship to poliomyelitis virus vaccines. Dev Biol Stand. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9776239
IOM. (2002). Immunization safety review: SV40 contamination of polio vaccine and cancer. Institute of Medicine. Retrieved from http://www.iom.edu/reports/2002/immunization-safety-review-sv40-contamination-of-polio-vaccine-and-cancer.aspx
Kihura Nkuba. (2002). Transcript. Polio vaccine genocide in Uganda. Retrieved from http://whale.to/a/nkuba.htm
Landaverde et al. (2001). Poliomyelitis outbreak caused by vaccine-derived virus in Haiti and the Dominican Republic. Rev Panam Salud Publica. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11418973
Lintas, C. (2010). Association of autism with polyomavirus infection in postmortem brains. J Neurovirol. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20345322
MedAlerts. (2013). Search the VAERS Database. Retrieved from http://www.medalerts.org/vaersdb/index.php
National Cancer Institute. (2011). Formaldehyde and Cancer Risk. National Institutes of Health. Retrieved from http://www.cancer.gov/cancertopics/factsheet/Risk/formaldehyde
Olmsted, D., Blaxill, M. (2011). The age of polio: How an old virus and new toxins triggered a man-made epidemic. Age of Autism. Retrieved from http://www.ageofautism.com/2011/09/the-age-of-polio-how-an-old-virus-and-new-toxins-triggered-a-man-made-epidemic-1.html
Opara, E. (2013). 120 arrested for refusing polio vaccine in Niger. Punch. Retrieved from http://www.punchng.com/news/120-arrested-for-refusing-polio-vaccine-in-niger/
PCT/US1998/027658. (1999). WO1999034825 fertility imparing vaccine and method of use. Patentscope. Retrieved from http://www.google.com/patents/WO1999034825A1
Post-Polio Health. (n.d.). Incidence rates of poliomyelitis in US. Post-Polio Health International. Retrieved from http://www.post-polio.org/ir-usa.html
Rana, S. (2011). Vaccine-nation: “Globally-supported company is funding fatal polio shots’”. The Express Tribune. Retrieved from http://tribune.com.pk/story/293191/vaccine-nation-globally-supported-company-is-funding-fatal-polio-shots/
Rosenthal et al. (1995). The reporting sensitivites of two passive surveillance systems for vaccine adverse events. Am J Public Health. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/7503351?dopt=Abstract
Sabin, A. (1959). Present position of immunization against poliomyelitis with live virus vaccines. BMJ. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993129/?page=12
Salk, J., Salk, D. (1977). Control of influenza and poliomyelitis with killed virus vaccines. Science. Retrieved from http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CC4QFjAA&url=http%3A%2F%2Fpromo.aaas.org%2Fkn_marketing%2Fpdfs%2FScience_1977_0304.pdf&ei=2AiWUrSrLsTwoAT5rICIDA&usg=AFQjCNH9w7Yr1Ni5sNNVkaZVYC8CmDRPgw&sig2=OyUXdIgAfK8_4GfBUMLsgw&bvm=bv.57155469,d.cGU&cad=rja
Sarkett, F. (2011). Nuclear risks in historical context. The Franc Report. Retrieved from http://thefranc.wordpress.com/2011/03/21/nuclear-risks-in-historical-context/
Shivapurkar et al. (2004). Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes. Cancer Res. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15172980?dopt=Abstract
The Nemours Foundation. (2013). Infections polio. KidsHealth. Retrieved from http://kidshealth.org/parent/infections/bacterial_viral/polio.html#
Vashisht, N., Puliyel, J. (2012). Polio programme: let us declare victory and move on. Indian J Med Ethics. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22591873
Wan, C. (2013). Viral meningitis. Medscape. Retrieved from http://emedicine.medscape.com/article/1168529-overview#a0156
Weisskopf, M., Morozova, N., O’Reilly E., McCullough, M., Calle, E., Thun, M., Ascherio, A. (2009). Prospective study of chemical exposures and amyotrophic lateral sclerosis. J Neruol Neurosurg Psychiatry. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19372290
Wu et al. (2013). Role of transient receptor potential ion channels and evoked levels of neuropeptides in a formaldehyde-induced model of asthma in BALB/c mice. PLoS One. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23671638
Wyatt, H. (2011). The 1916 New York epidemic of poliomyelitis: Where did the virus come from? The Open Vaccine Journal. Retrieved from http://search.yahoo.com/r/_ylt=A0SO80aCU5lSaxwAXFVXNyoA;_ylu=X3oDMTEzazA4NGQ2BHNlYwNzcgRwb3MDMQRjb2xvA2dxMQR2dGlkA1ZJUDI3NV8x/SIG=12kg5hkrf/EXP=1385808898/**http%3a//benthamscience.com/open/tovacj/articles/V004/13TOVACJ.pdf